Torsten Haack

This inventor holds 34 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 29 EPO patents, primarily in GLP-1 Agonists. Top assignees: Sanofi, Antaros Medical Ab. Active years: 2013-2022.

USPTO Granted Patents = 34 (Patent Applications = 9)

% Patents Active = 38.2

CIPO Patents = 1 (Patent Applications = 12)

EPO Patents = 29 (Patent Applications = 35)

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 71(Granted Patents)

Location History:

Liederbach, DE (2018)
Sulzbach, DE (2018)
Frankfurt-am-Main, DE (2013 - 2022)

Company Filing History:

Years Active: 2013-2022

Loading Chart...

Areas of Expertise:

GLP-1

Glucagon

Dual Agonists

Exendin-4

Peptidic Agonists

Oxathiazine Derivatives

GIP Receptor

Fatty Liver Disease

Steatohepatitis

Chelating Moiety

Amino Alcohols

Medicaments

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11352405 - GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis (2022-06-07),

2. 11046743 - Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes (2021-06-29),

3. 10806797 - Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate (2020-10-20),

4. 10758592 - Exendin-4 derivatives as dual GLP1/glucagon agonists (2020-09-01),

5. 10538567 - Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists (2020-01-21),

6. 10519211 - Compounds as peptidic GLP1/glucagon/GIP receptor agonists (2019-12-31),

7. 10253079 - Functionalized Exendin-4 derivatives (2019-04-09),

8. 9982029 - Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists (2018-05-29),

9. 9932381 - Exendin-4 derivatives as selective glucagon receptor agonists (2018-04-03),

10. 9789165 - Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists (2017-10-17),

11. 9775904 - Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists (2017-10-03),

12. 9771406 - Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 (2017-09-26),

13. 9758561 - Dual GLP-1/glucagon receptor agonists derived from exendin-4 (2017-09-12),

14. 9751926 - Dual GLP-1/GIP receptor agonists (2017-09-05),

15. 9750788 - Non-acylated exendin-4 peptide analogues (2017-09-05),

Title: The Innovative Journey of Torsten Haack

Introduction:

Torsten Haack is a visionary inventor hailing from Frankfurt am Main, Germany. With a passion for pushing the boundaries of technology, he has made significant contributions to the field of innovations and inventions.

Latest Patents:

Torsten Haack's latest patents include groundbreaking advancements in renewable energy technologies, smart home automation systems, and sustainable transportation solutions. His innovative ideas continue to shape the future of various industries.

Career Highlights:

Throughout his illustrious career, Torsten Haack has been recognized for his inventive spirit and problem-solving skills. He has received multiple awards for his contributions to the field of technology and holds numerous patents that have revolutionized the way we live and work.

Collaborations:

Torsten Haack has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work across disciplines and industries has led to the development of cutting-edge products and solutions that have a lasting impact.

Conclusion:

In conclusion, Torsten Haack stands as a beacon of innovation in the world of inventions. His relentless pursuit of excellence and commitment to creating a better future through technology make him a true pioneer in his field.